This most up-to-date twist during the Lykos Therapeutics saga threatens A significant overhaul of the business’s approach and way, with Musk ally and billionaire investor Antonio Gracias appearing to want to choose the corporate back again towards its nonprofit drug progress roots and a far more Doblinite philosophy.By signing up into the copyrig